CAMP4 Therapeutics logo

CAMP4 Therapeutics

CAMP | NASDAQ
Chart Builder DCF Calculator
$3.86
+$0.06 (+1.58%)
At close: Nov 16, 2026, 4:00 PM ET
$3.62
-$0.24 (-6.11%)
After-hours: Nov 16, 2026, 7:52 PM ET
+1.58%

No price chart data available for 1D timeframe.

Rating

Updated: Nov 14, 2026
40.2
+5.4 pts
Fundamentals Average
Market Sentiment Neutral
Moat None
Sector Rank #522/1021 (Top 51%)

Key Statistics

Market Data

Market Cap $304.73M
1D Range
3.58 4.05
52W Range
2.90 7.13

Valuation (TTM)

PE -1.88
PB 2.85
EV/EBITDA -2.59

Valuation (NTM)

Forward PE N/A
Forward PEG 0.05
Price Target $9.00
Loading financial charts...

Profile

CAMP4 Therapeutics Corporation, a biotechnology firm, was established in 2015 by Richard A. Young and Leonard Zon. Based in Cambridge, Massachusetts, its core focus is the identification and developme...

Sector Healthcare
Industry Biotechnology
Employees 48
IPO Date Oct 11, 2024
Fiscal Year March - February

Latest News

No news articles available yet.

Earnings

Latest Earnings
Nov 5, 2026
EPS
-$0.37
Miss -90.94%
REV
$1.9M
Beat +10.62%
Next Earnings
Mar 4, 2027
EPS Est
Pro
Rev Est
Pro
Earnings Details ➞

Analyst Summary

# of Analysts
4
Consensus
Buy
Price Target
$9.00
Upside
+133.16%
Buy (4)
Hold (0)
Sell (0)
Analyst Details ➞

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.